Join to View Full Profile
1221 Madison StSeattle, WA 98104
Phone+1 206-386-2323
Fax+1 206-386-2729
Are you Dr. Rivkin?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Saul Rivkin, MD is a hematologist in Seattle, Washington. He is currently licensed to practice medicine in Washington.
Education & Training
University of New Mexico School of MedicineResidency, Internal Medicine, 1970 - 1971- University of New Mexico School of MedicineResidency, Internal Medicine, 1965 - 1968
University of Cincinnati Medical Center Inc.Internship, Transitional Year, 1964 - 1965
University of Washington School of MedicineClass of 1964
Certifications & Licensure
WA State Medical License 1965 - 2022
Publications & Presentations
PubMed
- 11 citationsPhase Ib with expansion study of olaparib plus weekly (Metronomic) carboplatin and paclitaxel in relapsed ovarian cancer patientsSaul E. Rivkin, James Moon, Desiree Iriarte, Erik Bailey, Heather L. Sloan
International Journal of Gynecological Cancer. 2019-01-29 - 21 citationsA phase I trial of intraperitoneal nab-paclitaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavityMihaela C. Cristea, Paul Frankel, Timothy W. Synold, Saul E. Rivkin, Dean Lim
Cancer Chemotherapy and Pharmacology. 2019-01-08 - 17 citationsColorectal Chemoprevention Pilot Study (SWOG-9041), randomized and placebo controlled: the importance of multiple luminal lesions.David Chu, Michael A. Hussey, David S. Alberts, Frank L. Meyskens, Cecilia M. Fenoglio-Preiser
Clinical Colorectal Cancer. 2011-12-01
Press Mentions
Olaparib Tablet Safe in Pretreated Ovarian Cancer PatientsSeptember 10th, 2014
